PITPs as targets for selectively interfering with phosphoinositide signaling in cells by Nile, Aaron H et al.
PITPs as Targets for Selectively Interfering With 
Phosphoinositide Signaling in Cells
Aaron H. Nile1,2, Ashutosh Tripathi1,3,*, Peihua Yuan1, Carl J. Mousley1, Sundari Suresh4, 
Iain Michael Wallace4, Sweety D. Shah2, Denise Teotico Pohlhaus3, Brenda Temple5, Corey 
Nislow6, Guri Giaever6, Alexander Tropsha3, Ronald W. Davis4, Robert P. St Onge4, and 
Vytas A. Bankaitis1,2,*
1Department of Molecular & Cellular Medicine, Department of Biochemistry & Biophysics, 
Department of Chemistry, Texas A&M University, College Station, Texas 77843-1114 USA
2Department of Cell & Developmental Biology, Lineberger Comprehensive Cancer Center, 
University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7090 USA
3Laboratory for Molecular Modeling, Eshelman School of Pharmacy, University of North Carolina 
at Chapel Hill, Chapel Hill, North Carolina 27599-7355 USA
4Department of Biochemistry, Stanford Genome Technology Center, Stanford University, Palo 
Alto, CA 94304
5R. L. Juliano Structural Bioinformatics Core, University of North Carolina at Chapel Hill, Chapel 
Hill, North Carolina 27599-7260 USA
6Faculty of Pharmaceutical Sciences,, University of British Columbia, Vancouver, BC V6T 1Z3, 
Canada
Abstract
Sec14-like phosphatidylinositol transfer proteins (PITPs) integrate diverse territories of 
intracellular lipid metabolism with stimulated phosphatidylinositol-4-phosphate production, and 
are discriminating portals for interrogating phosphoinositide signaling. Yet, neither Sec14-like 
PITPs, nor PITPs in general, have been exploited as targets for chemical inhibition for such 
purposes. Herein, we validate the first small molecule inhibitors (SMIs) of the yeast PITP Sec14. 
These SMIs are nitrophenyl(4-(2-methoxyphenyl)piperazin-1-yl)methanones (NPPMs), and are 
effective inhibitors in vitro and in vivo. We further establish Sec14 is the sole essential NPPM 
target in yeast, that NPPMs exhibit exquisite targeting specificities for Sec14 (relative to related 
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Sec14-like PITPs), propose a mechanism for how NPPMs exert their inhibitory effects, and 
demonstrate NPPMs exhibit exquisite pathway selectivity in inhibiting phosphoinositide signaling 
in cells. These data deliver proof-of-concept that PITP-directed SMIs offer new and generally 
applicable avenues for intervening with phosphoinositide signaling pathways with selectivities 
superior to those afforded by contemporary lipid kinase-directed strategies.
Lipid signaling modulates a wide range of cellular processes, including regulation of G-
protein-coupled receptors and receptor tyrosine kinases at the plasma membrane1, actin 
dynamics2, transcription3,4, and membrane trafficking5. A major pillar of eukaryotic lipid 
signaling is defined by phosphoinositides and the soluble inositol (Ins) phosphates derived 
from them6,7. Phosphatidylinositol (PtdIns) is an essential phospholipid that serves as 
metabolic precursor for both phosphoinositides and Ins-phosphates. While Ins-phosphates 
are chemically diverse, the phosphoinositide cabal is simpler. Yeast produce five 
phosphoinositides (PtdIns-3-phosphate, PtdIns-4-phosphate, PtdIns-5-phosphate, PtdIns-4,5-
bisphosphate, and PtdIns-3,5-bisphosphate) while mammals produce seven; those 
synthesized by yeast as well as PtdIns-3,4-bisphosphate and PtdIns-3,4,5-trisphosphate6. 
This limited phosphoinositide cohort supports a diverse landscape of lipid signaling that 
modulates the actions of hundreds of proteins7.
Specific inactivation of a target enzyme is a desirable instrument for dissecting mechanisms 
of lipid signaling in cells. This is especially true in the context of phosphoinositide signaling 
whose very diversification demands highly targeted approaches for clean analysis. However, 
specific genetic or chemical interventions at the level of individual lipid kinases, or 
compartment-specific interventions at the level of defined phosphoinositide species using 
Rapalog technologies8,9, remain blunt experimental instruments. Such interventions exert 
pleiotropic effects because many effector activities are impaired upon inhibition of a target 
Ins-lipid kinase, or upon compartment-specific depletion of a specific phosphoinositide 
species.
PtdIns-transfer proteins (PITPs) of the Sec14 protein superfamily are key regulators of 
phosphoinositide signaling that specify discrete biological outcomes of PtdIns kinase 
action10,11. Deficiencies in individual Sec14-like PITPs compromise trafficking through the 
trans-Golgi network (TGN) and endosomal systems12, phosphatidylserine decarboxylation 
to phosphatidylethanolamine13, fatty acid metabolism14, polarized growth15, and fungal 
dimorphism16. Mutations in PITPs, or PITP-like proteins, are also root causes of 
mammalian neurodegenerative and lipid homeostatic diseases17,18.
Various lines of evidence recommend PITPs as highly discriminating portals for 
interrogating phosphoinositide signaling, and identify PITPs as unexploited avenues for 
chemical inhibition of select phosphoinositide signaling pathways in cells. Herein, we 
exploit the yeast system to make the case. We validate the first chemical inhibitors of a 
PITP, demonstrate an exquisite in vivo specificity of action for such compounds, and 
propose a chemical mechanism for how these SMIs exert their inhibitory effects. These 
studies deliver proof-of-concept that PITP-directed approaches afford powerful advantages 
for chemically intervening with phosphoinositide signaling, and that the selectivities 
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achieved are superior to those delivered by strategies targeting individual PtdIns-kinase 
isoforms or individual phosphoinositide species.
RESULTS
Candidate Sec14-directed SMIs
Sec14, the major yeast PITP, is an essential protein required for membrane trafficking 
through the TGN/endosomal system12. Chemogenomic profiling of 188 inhibitors of yeast 
growth identified a candidate for a Sec14-directed SMI19. This compound, 4130-1278 (1), is 
a 4-chloro-3-nitrophenyl)(4-(2-methoxyphenyl) piperazin-1-yl)methanone (NPPM). Since 
4130-1278 exhibited mediocre potencies, and limited water solubility, we evaluated 13 other 
NPPM-like SMIs as Sec14 candidate inhibitors (Supplementary Results, Supplementary Fig. 
1a). One such derivative, 4130-1276 (2), showed superior water solubility and arrested 
growth of a sec14Δ/SEC14 heterozygous strain at 10-fold lower concentrations than those 
observed for 4130-1278 (Supplementary Fig. 1b).
Chemogenomic profiling of ca. 6200 yeast deletion strains correlated gene-dosage with 
yeast sensitivity to 4130-1278 or 4130-1276 challenge on a genome-wide scale 
(Supplementary Fig. 2a–f). The profiling identified sec14Δ/SEC14 heterozygous diploid 
cells as the most sensitive to 4130-1278 and 4130-1276 challenge of all homozygous Δ/Δ 
and heterozygous Δ/+ diploids tested (non-essential and essential gene queries, respectively; 
Supplementary Fig. 2a–f). A limited set of other genes was also identified for which dosage 
reduction decreased fitness in the presence of 4130-1278 and 4130-1276 (Supplementary 
Fig. 2c, f). Gene functions identified in the more extensive 4130-1276 hit list included Golgi 
trafficking, sporulation, exocytosis, vacuolar transport, and lipid metabolism. A number of 
high scoring chemogenomic interactions, include phospholipase D (SPO14), a strong 
synthetic interactor with sec14-1ts 10,20 and the phospholipase D regulator SRF121, were 
independently recognized in genome-scale synthetic genetic array (SGA) screens that 
employed sec14-1ts as query allele22,23.
Expansion of the candidate Sec14-directed SMI set
In focused searches for additional candidate Sec14-targeted SMIs, an expanded set of 34 
compounds was assembled around the 4130-1276 scaffold. For initial rounds of compound 
selection, the Chembridge library was filtered using Similarity Search (Marvin Applet tool, 
Hit2Lead – Cambridge database). The filter clamped structural similarity to ca. 80% of the 
query 4130-1276 molecule and highlighted functional groups as sites for diversification 
(Supplementary Fig. 3a, b). NPPMs 4130-1276, 67170-49 (3) and 6748-481 (4) were chosen 
for study because these were potent growth inhibitors. The closely related 5564-701 (5) 
elicited no growth inhibitory effects and served as negative control. Structures of the five 
NPPMs of interest are shown in Figure 1a.
Sensitivity to NPPM is a function of Sec14 levels
Dose response experiments showed NPPM sensitivity was related to cellular Sec14 levels. 
NPPM 6748-481 served as representative SMI in these assays as it was the most water 
soluble bioactive compound and the most potent growth inhibitor. The half-maximal 
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inhibitory concentration (IC50) for 6748-481 was 2.9 ± 0.6 μM for WT haploid cells (Fig. 
1b). When endogenous Sec14 levels were reduced ~7-fold by driving SEC14 expression 
from a truncated promoter (SEC14P-136) 24, the IC50 fell proportionately. The effect was 
specific as SEC14P-136 haploids were not sensitized to the inactive 5564-701 (Fig. 1b), and 
elevated Sec14 levels enhanced resistance to 6748-481 (Fig. 1c).
NPPMs inhibit Sec14 in vitro
As Sec14 is not an enzyme, its activity is operationally defined by exchange of PtdIns and 
PtdCho between membranes in vitro10. NPPMs 67170-49, 6748-481 and 4130-1276 
displayed potent and dose-dependent inhibitions of Sec14-catalyzed [3H]-PtdIns transfer in a 
purified system. The IC50s ranged from 175–283nM (Fig. 1d). At these concentrations, the 
Sec14:NPPM molar stoichiometries were ca. 1:1.
Two results excluded trivial possibilities that NPPMs interfered with Sec14 activities via 
non-specific membrane-active effects. First, biologically inactive NPPMs (5564-701) failed 
to diminish Sec14-catalyzed PtdIns-transfer at concentrations 500-fold above the IC50s 
measured for Sec14-active NPPMs (Fig. 1d; Supplementary Fig. 4). Second, neither of the 
Sec14-active NPPMs tested (6748-481 and 4130-1276; 40μM) interfered with [3H]-PtdIns 
transfer activities of other yeast Sec14-like PITPs (Sfh1–Sfh525) -- even at concentrations 
~200-fold greater than the corresponding Sec14 IC50s (Fig. 1e). Sfh protein indifference to 
NPPMs demonstrated selectivity of the SMIs for Sec14 as Sfh PITPs share 23%–64% 
primary sequence identity with Sec14 (43%–89% similarity). That Sfh1-mediated transfer 
activities were not inhibited underscored the Sec14 selectivity of these NPPMs as Sfh1 is the 
closest known Sec14 homolog26.
NPPM structure activity relationships
Forty-six NPPM-like molecules were evaluated for structure-activity relationships (SAR) for 
Sec14 inhibition. The cumulative SAR data assigned the relative importance of each NPPM 
functional group to activity as Sec14 inhibitor (IC50<10μM in vitro activity threshold). SAR 
reported an obligatory requirement for ortho-Cl in the Cl-nitrophenyl (i.e. activated aryl 
halide) NPPM moiety (Fig. 2a; Supplementary Figs. 3,4). Either Cl- removal (4130-1276 vs. 
5355-152 [6]), or Cl- shift to the para position (4130-1276 vs. 5658-722 [7]), increased the 
Sec14 IC50 >500-fold (Fig. 2b). The linker ketone that connects the Cl-nitrophenyl and 
piperazinyl groups was key. Its modification reduced NPPM potency in vitro by 30-fold 
(6748-481 vs. 5263-433 [8]). The NO2-group also contributed to NPPM potency. Its 
removal resulted in a ~10-fold increase in IC50 (6748-481 vs. 5357-399 [9]; Supplementary 
Fig. 4). Addition of hydrophobic functional groups to the NPPM fluorobenzene tail 
enhanced potency ca. 4-fold (compare 5348-909 [10] with 6748-481, 7276-196, [11] and 
6828-980 [12]). However, extending the linker that bridges the piperazinyl and 
fluorobenzene groups by a single carbon reduced NPPM potency (5348-909 vs. 5356-684 
[13]; Supplementary Figs. 3,4).
Sec14 inhibition and the NPPM halide
The ortho-Cl requirement on the activated aryl halide raised the question of how halide 
identity influences NPPM potency. A variable aryl halide series was assembled 
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[(BBV34896-755 [14], BBV34846-244 [15], Z1082669-326 [16]), and 6748-481 was 
resynthesized for inclusion in the series (BBV34846-247 [17]). The Cl-, Br- and I- 
derivatives (4130-1276 and 6748-481; BBV34846-244; Z1082669-326) exhibited potencies 
superior to those of the H-, CH3- or F-derivatives (5355-152, 5348-723 [18], 
BBV34896-755). In rank order: Br-NPPM > I-NPPM ≥ Cl-NPPM (6748-481; 
BBV34846-247) ≫ F-NPPM, CH3-NPPM, H-NPPM (Fig. 2c, Supplementary Fig. 4). 
Consistent with in vitro data, Cl-, Br- and I- versions were potent growth inhibitors, whereas 
H-, CH3- and F- derivatives were not (Supplementary Fig. 3).
Six ‘NO2-less’ derivatives, differing in halide chemistry and/or position, were evaluated 
(5356-628 [19], 5356-350 [20], 5567-782 [21], 5357-399, 5353-036 [22], 7329-906 [23], 
5355-139 [24], 5528-054 [25]). The relative potencies of these compounds as Sec14 
inhibitors were also directly proportional to the atomic mass and lipophilicities of the ortho-
halide, and inversely proportional to halide electronegativity (Fig. 2d, Supplementary Fig. 
4). The ortho-halide requirement for SMI activity was conserved (Fig. 2e, Supplementary 
Fig. 4). Parallel in vivo experiments demonstrated Cl-, Br- and I- compounds potently 
inhibited growth, whereas H-, CH3- and F- derivatives did not (Supplementary Fig. 3).
NPPM binding models
NPPMs are amphipathic molecules that partition into apolar environments (ClogP ~ 3.0), 
suggesting NPPMs load into the Sec14 hydrophobic pocket during phospholipid exchange. 
To address how Sec14 binds NPPMs, a 1400Å2 virtual pocket surface was modeled to form 
a boundary for unconstrained docking routines using 6748-481 as ligand (Supplementary 
Fig. 5). Multiple independent simulations, using several docking platforms, produced >3000 
binding solutions that reduced themselves into 6 representative modes. These modes shared 
certain features with regard to Sec14::6748-481 interactions, but exhibited unique features 
as well (Supplementary Figs. 6,7). Two pose classes (modes 1,2 and modes 3,4) represented 
mirror images where orientations of bound 6748-481 were rotated 180° around the NPPM 
long axis. Another pose class (modes 5,6) shifted the 6748-481 binding site down the 
hydrophobic pocket. Sec14::NPPM interaction fingerprints highlighted how modes 5,6 
forced NPPM polar groups into hydrophobic environments (Supplementary Figs. 6,7). This 
unappealing feature led us to reject mode 5,6 poses from consideration.
Fingerprints common to modes 1,2 and 3,4 included intercalation (in flipped orientation) of 
the 6748-481 fluorobenzene tail into the narrow hydrophobic cleft lined by Sec14 residues 
L232, F228, F225, I240, F221, L179, I214, and M177 (Supplementary Figs. 6,7), and wedge of 
the fluoro-benzyl moiety between the side chains of F228 on one side and F212 and M177 on 
the other; thereby consolidating a network of hydrophobic and π-π stacking interactions. A 
second common fingerprint inter-digitated the 6748-481 chloro-nitrophenyl group in a 
hydrophilic subdomain of the Sec14 pocket where it set within H-bonding distance (1.5–
3.5Å) to residues framing the Sec14 PtdCho headgroup-coordinating substructure (S173, 
Y111, Y122, Y151; Supplementary Figs. 6,7). All modes predicted NPPM-binding was 
sterically incompatible with PtdIns/PtdCho-binding (Supplementary Fig. 7b).
Modes 1,2 were distinguished from modes 3,4 by orientation of the 6748-481 ketone. Modes 
1,2 anchored the ketone via H-bond interactions with S201, whereas modes 3,4 assigned 
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ketone interactions with Y151. Modes 1 and 2 were further distinguished by their mirror-
image orientation of the activated aryl halide. Mode 1 anchored the nitro- group by 
interactions with residues S173/Y122 and the halide with Y111/S173. Mode 2 featured nitro- 
and halide interactions with S173 and Y111/Y122, respectively. Mode 3 assigned interactions 
of the nitro- and halide groups with residues S173 and Y111, respectively, whereas mode 4 
projected both the nitro- and halide groups engage S173/Y111. In sum, the solution sets 
projected Sec14 S173, Y111, Y122, and Y151 interactions with activated aryl halide (albeit in 
flipped orientations), and anchor of the ketone to S201 or Y151.
NPPM-resistant Sec14
The NPPM docking models made distinguishing predictions regarding which missense 
substitutions should diminish NPPM binding without affecting Sec14 activity. The 
corresponding Sec14 proteins were purified and assayed for PtdIns transfer activity. Residue 
S173 was of particular interest as it was consistently identified as highest scoring NPPM-
interacting residue in docking simulations. Indeed, S173C rendered Sec14 resistant to 
inhibition by NPPM 6748-481 in vitro -- even at concentrations approaching NPPM 
solubility limits (>736-fold more resistant than Sec14: Supplemental Figs. 8a). Specificity of 
effect was evident by the more modest NPPM-resistance exhibited by 
Sec14T175C(Supplemental Figs. 8a), and Sec14S173C resistance translated across the 
spectrum of Sec14-active NPPMs (Supplementary Fig. 8b, c). Strong reductions in 
6748-481 sensitivity were also scored for Sec14Y111A, Sec14Y151A and Sec14S201C (Fig. 3a, 
Supplemental Fig. 9a–c). The corresponding PtdIns-transfer activities were 337-, 140- and 
22-fold less sensitive to 6748-481 inhibition (Fig. 3a, Supplemental Fig. 9a–c). Sec14Y111F, 
Sec14Y122A, Sec14M177C and Sec14Y122F showed only ~2- to 5-fold reductions in the same 
(Fig. 3a, Supplemental Fig. 9a, b, d, e.), whereas Sec14Y151F displayed modestly enhanced 
sensitivity to 6748-481 (Fig. 3a, Supplemental Fig. 9a, b, e).
Sec14 is the sole essential NPPM target
Two lines of evidence demonstrated that Sec14 represents the sole essential NPPM target in 
cells. First, yeast expressing Sec14S173C were resistant to challenge with 6748-481 (Fig. 3b). 
The second came from exploitation of ‘bypass Sec14’ mutants that no longer require Sec14 
for viability. Genetic inactivation of the CDP-choline pathway for PtdCho biosynthesis 
(cki1Δ), or of the oxysterol binding protein homolog Kes1 (kes1Δ), effects ‘bypass 
Sec14’27–30. Both cki1Δ and kes1Δ cells were indifferent to 6748-481, 67170-49 or 
4130-1276 (Fig. 3c).
NPPM challenge phenocopies genetic inactivation of Sec14
Sec14 promotes membrane trafficking through the TGN/endosomal system by coordinating 
PtdCho and PtdIns-4-phosphate (PtdIns-4-P) metabolism22,28,30. Thermal inactivation of 
Sec14 (by shift of sec14-1ts mutants to 37°C) provoked intracellular accumulation of cargo-
engorged TGN/endosomes. These morphological phenotypes were recapitulated in WT and 
SEC14P-136 cells intoxicated with NPPMs 6748-481, 67170-49 or 4130-1276 
(Supplementary Fig. 10). Mock challenge with DMSO, or with inactive 5564-701 control, 
had no effect. The kes1Δ and cki1Δ ‘bypass Sec14’ mutants were unaffected by 6748-481, 
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67170-49, or 4130-1276 (Supplementary Fig. 11), and cells expressing Sec14S173C were 
similarly unperturbed by NPPM challenge (Supplementary Fig. 12).
The trafficking defects induced by NPPM-poisoning were also on display when transport 
and/or recycling of cargo through the TGN/endosomal system were analyzed. Endocytic 
transport of the bulk membrane tracer FM4-64 to the limiting vacuole membrane 
(Supplementary Fig. 13a, b), and recycling of endocytosed Snc1 v-SNARE from TGN/
endosomes to the cell surface, were both retarded by 6748-481, 67170-49 or 4130-1276 
(Supplementary Fig. 14a, b). Mock challenge with DMSO or 5564-701 was without effect. 
Trafficking of secretory invertase to the cell surface was also impaired upon 6748-481, 
67170-49, or 4130-1276 challenge, but not by 5564-701 or DMSO (Supplementary Fig. 15). 
NPPM-induced FM4-64, GFP-Snc1, and invertase trafficking defects were corrected by 
kes1Δ (Supplementary Figs. 16a–d). Sec14S173C expression similarly rendered invertase 
secretion resistant to inhibition by Sec14-active NPPMs, (Supplementary Fig. 17).
The effects of NPPM challenge on transit of vacuolar carboxypeptidase Y (CPY) through 
the TGN/endosomal system were monitored by pulse-chase radiolabeling. Impaired 
trafficking from ER or TGN compartments was diagnosed by accumulation of CPY 
precursor forms (p1 and p2)31. Pools of p1CPY, and particularly of p2CPY, accumulated 
when sec14-1ts yeast were shifted to restrictive temperatures (37°C) and upon treatment of 
WT or SEC14P-136 cells with NPPMs 6748-481, 67170-49 or 4130-1276 (Supplementary 
Fig. 18a, b). Neither DMSO, nor 5564-701, impaired CPY transport from ER or TGN/
endosomal compartments in WT or SEC14P-136 cells. The inhibitory effects of Sec14-active 
NPPMs on CPY trafficking were dose-and time-dependent (Supplementary Fig. 19a, b), and 
were poorly reversible. Precursor CPY forms failed to chase to mCPY – even after a 2hr 
washout period with cycloheximide (Supplementary Fig. 20). Finally, NPPM 6748-481, 
67170-49, and 4130-1276-mediated inhibition of CPY transit through the secretory pathway 
was remediated in kes1Δ and cki1Δ ‘bypass Sec14’ mutants (Supplementary Fig. 21, a, b), 
and in cells expressing Sec14S173C as sole Sec14 source (Supplementary Fig. 21c).
NPPMs discriminate between phosphoinositide pools
Sec14 potentiates activities of both essential yeast PtdIns 4-OH kinases in vivo (i.e. Stt4 and 
Pik1)10,32–34. We therefore tested whether bulk PtdIns-4-P production was sensitive to 
inhibition by Sec14-active NPPMs. In these experiments, sac1 mutants inactivated for the 
major yeast PtdIns-4-P phosphatase were employed because these mutants accumulate 
PtdIns-4-P to high levels33,35. This accumulation simplifies PtdIns-4-P biosynthetic rate 
measurements, and increases statistical power of PtdIns-4-P quantification. Challenge with 
6748-481, 67170-49, 4130-1276, reduced bulk PtdIns-4-P levels by ~40% compared to 
levels recorded when cells were challenged with DMSO or 5564-701 (Supplementary Fig. 
22a). Neither challenge with 6748-481, nor with 5564-701, affected PtdIns-3-P or 
PtdIns-4,5-bisphosphate (PtdIns-4,5-P2) levels when compared to vehicle alone 
(Supplementary Fig. 22b, c).
NPPM selectivity on phosphoinositide homeostasis in WT yeast was also on display in vital 
imaging assays using isomer-selective biosensors. To probe status of PtdIns-4,5-P2 pools, 
we monitored intracellular distribution of the GFP-2xPHPLCδ1 PtdIns-4,5-P2 biosensor. This 
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reporter localized to the plasma membrane in a PtdIns-4,5-P2-dependent manner -- as 
evidenced by biosensor release into the cytoplasm upon inactivation of a temperature-
sensitive version of the single yeast PtdIns-4-P 5-OH kinase (Mss4; Supplementary Fig. 
22d, e). In accord with [3H]-inositol radiolabeling data, GFP-2xPHPLCδ1 remained bound to 
plasma membrane after 3h incubation of cells with Sec14-active SMIs. Release of 
GFP-2xPHPLCδ1 from plasma membrane was not observed upon inactivation of other PtdIns 
kinases (Supplementary Fig. 22d, e).
Status of TGN/endosomal PtdIns-4-P pools was queried using two biosensors; GFP-
GOLPH3 and GFP-2xPHOsh2 36–38. Optimal association of both reporters with TGN/
endosomal compartments was unaffected in cells devoid of PtdIns-3-phosphate and 
PtdIns-3,5-P2 (vps34Δ), but was Pik1-dependent as evidenced by release from these 
organelles upon shift of pik1ts mutants to 37°C (Supplementary Fig. 23a–d). Thermal 
inactivation of Sec14 (sec14ts mutant, 37°C condition), or intoxication of yeast with 
6748-481, 67170-49, or 4130-1276, similarly released GFP-2xPHOsh2 from TGN/endosomal 
structures (Fig. 4a, b). A compartmental pool-specificity was evident for NPPM-mediated 
interference of PtdIns-4-P signaling in these experiments. In addition to the Sec14- and 
Pik1-dependent TGN/endosomal PtdIns-4-P pool, GFP-2xPHOsh2 registered an Stt4-
dependent plasma membrane pool of this phosphoinositide (Fig. 4a, b; Supplementary Fig. 
23a, b). Challenge of WT cells with 6748-481, 67170-49 or 4130-1276 (but not 5564-701 or 
DMSO) released GFP-2xPHOsh2 from TGN/endosomal compartments -- without 
compromising biosensor targeting to the plasma membrane (Fig. 4a, b). In that regard, we 
previously showed that kes1Δ rescues growth defects of pik1ts, but not stt4ts, mutants at 
semi-permissive temperatures29 – identifying Kes1 as an antagonist of Pik1-dependent 
PtdIns-4-P signaling. The kes1Δ ‘bypass Sec14’ mutant retained GFP-2xPHOsh2 on TGN/
endosomal membranes in the presence of 6748-481, 67170-49, or 4130-1276 
(Supplementary Fig. 24a, b).
Compartmental pool-specificities for NPPM-mediated interference of PtdIns-4-P signaling 
were also evident in GFP-GOLPH3 imaging experiments. The effects of genetic and NPPM-
mediated Sec14 inactivation on GFP-GOLPH3 localization differed from those observed for 
GFP-2xPHOsh2 as these conditions effected morphological derangement of GFP-GOLPH3-
positive TGN/endosomal compartments. Significant, but more limited, release of the 
reporter from TGN/endosomal membranes was observed (Fig. 4c, d; Supplementary Fig. 
23c, d).
NPPMs discriminate between local PtdIns-4-P pathways
The GFP-2xPHOsh2 imaging results demonstrated Sec14-active SMIs disrupted PtdIns-4-P 
signaling in a compartment-specific manner (TGN/endosomes vs. plasma membrane). The 
distinct biological activities of Sec14 and the Sec14-like Sfh4 provided a more discerning 
test of whether Sec14-active NPPMs distinguished between parallel PtdIns-4-P signaling 
pathways that operate in the same endomembrane system. Sec14 and Sfh4 both control 
PtdIns-4-P production in TGN/endosomes. Unlike Sec14, Sfh4-dependent PtdIns-4-P 
signaling supports phosphatidylserine (PtdSer) decarboxylation to 
phosphatidylethanolamine (PtdEtn) in those compartments (Fig. 5a) 13. As PtdEtn is an 
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essential lipid, loss of Sfh4 activity resulted in Etn auxotrophy when the PtdSer 
decarboxylase 1 pathway was incapacitated (psd1Δ; Fig. 5b).
Because Sfh4 was not inhibited in vitro by Sec14-active NPPMs, we examined whether 
Sec14-active SMIs respected the PtdIns-4-P pool-selectivities of these distinct PITP-
dependent metabolic circuits. Thus, psd1Δ yeast were reconstituted for Sec14S173C 
expression (to circumvent NPPM-induced growth defects associated with Sec14 
inactivation), and cells were intoxicated with 6748-481. NPPM challenge failed to impose 
Etn auxotrophy onto the PSD1 control, or onto the isogenic psd1Δ derivative (Fig. 5b) – 
thereby demonstrating that Sfh4 retained biological activity in the face of Sec14-active 
NPPM.
These phenotypic results were confirmed by [3H]-serine radiolabeling experiments that 
measured Sfh4-dependent decarboxylation of PtdSer to PtdEtn in TGN/endosomes. NPPM 
6748-481 challenge of psd1Δ mutants did not compromise PtdSer decarboxylation in vivo. 
This result was observed regardless of whether psd1Δ mutants expressed Sec14 (TGN/
endosomal trafficking was blocked) or Sec14S173C (cells remained competent for TGN/
endosomal trafficking; Fig. 5c). Thus, NPPM challenge failed to interfere with Sfh4-
dependent PtdIns-4-P signaling in TGN/endosomes even as it strongly impaired Sec14-
dependent PtdIns-4-P signaling in the same endomembrane system.
DISCUSSION
Using a rigorous set of genetic and biochemical criteria, we identify NPPMs as the first 
validated Sec14-directed inhibitors, and establish PITPs as pharmacological targets for high 
resolution dissection of PtdIns-4-P signaling in cells. Our findings emphasize the exquisite 
PITP selectivities of NPPMs, and demonstrate these compounds do not exert their effects 
via non-specific membrane-active mechanisms. Rather, the data indicate NPPMs load into 
the Sec14 hydrophobic pocket during a phospholipid exchange cycle, and invade PtdIns- 
and PtdCho-acyl chain space while simultaneously engaging Sec14 residues essential for 
PtdCho headgroup coordination. NPPM engagement of Sec14 residues essential for 
coordinating the PtdCho headgroup rationalizes the PITP-selectivities of NPPMs. Other 
Sec14-like PITPs do not conserve the PtdCho headgroup coordinating substructure 
(Supplementary Fig. 25), and therefore lack the structural elements required for NPPM 
binding. In this regard, Sfh1 presents a conundrum as it is highly homologous to Sec14 and 
conserves the functional PtdCho-coordinating unit critical for NPPM binding. Subtle 
differences in Sec14 vs Sfh1 pocket geometry likely account for the NPPM-resistance of 
Sfh1. However, given Sec14-like PITPs conserve the PtdIns-binding ‘barcode’10,18, the 
structural engineering of these proteins also offers prospects for development of broad range 
inhibitors which survey the PtdIns-headgroup binding site.
The chemical properties of activated aryl halides suggest several mechanisms for how 
NPPMs inhibit Sec14 activity. One involves aromatic nucleophilic substitution39, but the 
potency vector of the ortho-halide NPPM series excludes such mechanisms. Rather, we 
favor non-covalent halogen bonding mechanisms40,41 (Fig. 6a). Halogen bond interactions 
require formation of an electropositive ‘σ-hole’ on the charge surface of the halogen. This 
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organization is enhanced by vicinal e- withdrawing groups (e.g. -NO2), and by propensities 
of larger halide atoms to adopt anisotropic distributions of electrostatic potentials41,42. 
Correlations of Sec14-active NPPM potencies with electrostatic surface potentials of 
cognate activated aryl halides support halogen bonding mechanisms for NPPM-mediated 
Sec14 inhibition. Our calculations project NPPM activated aryl halides form σ-holes, and 
that σ-hole magnitudes are inversely proportional to halide electronegativity (Fig. 6a). This 
relationship is congruent with experimentally determined NPPM potencies as Sec14 
inhibitors. We propose NPPM occupancy in the Sec14 pocket is anchored by S173 
engagement with ortho-halide via halogen bond, NO2-group engagements with Y111 and 
Y151, H-bond interaction of the ketone with S201, and intercalation of the NPPM 
fluorobenzene between F228 of the helical gate and F212/M177 of the pocket floor (Fig. 6b, 
c). Proof of a halogen-bonding mechanism requires structural data, however, as the cardinal 
signature is a ‘short’ halide-oxygen bond whose length is less than the sum of the halide and 
oxygen van der Waals radii40–42.
How does non-covalent NPPM binding in the Sec14 pocket exert a poorly reversible 
inhibition of PITP activity? NPPM-mediated bridging of the pocket floor to gate sub-
structures might tether these elements too strongly for Sec14 to spring the gate for ligand 
exchange upon membrane association. Alternatively, Sec14-active NPPMs may decouple 
conformational switch elements required for gate opening by disturbing H2O networks that 
lubricate the pocket surface43 -- thereby locking Sec14 in a ‘closed’ NPPM-bound state.
The availability of powerful yeast genetic technologies notwithstanding, we forecast 
significant utility for Sec14-active NPPMs as tool compounds. For example, these SMIs 
circumvent the tedium of incorporating sec14ts mutations into large sets of isogenic yeast 
strains for running genome-scale screens. Sec14-active SMIs also enable manipulation of in 
vitro membrane trafficking assays reconstituted with wild-type components – a significant 
advantage given productive exploitation of genetic tools in cell-free systems is often 
frustrated by misbehavior of mutant biochemical fractions.
Finally, as PITPs are ubiquitously distributed across the Eukaryota44, PITP-directed 
screening platforms offer new applications for drug discovery. Because expression of 
heterologous Sec14-like proteins, or structurally-unrelated mammalian StART-like PITPs, 
rescue Sec14 defects in yeast45, such platforms can be purposed for discovery of SMIs 
directed against target PITPs derived from many biological sources. PITP inhibitors, 
whether directed against Sec14-like or StART-like PITPs, will enable study of 
phosphoinositide signaling in organisms intractable to genetic approaches. Many such 
organisms are significant pathogens. In that regard, we have identified new classes of PITP-
directed SMIs that inhibit dimorphic transitions of pathogenic fungi – i.e. inhibit the 
developmental processes essential to success of these organisms as infectious agents.
ONLINE METHODS
Statistical analyses
Curve fitting and t-test were performed using GraphPad Prism version 5.00 for Windows, 
GraphPad Software, La Jolla California USA (www.graphpad.com) unless otherwise noted. 
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General data handling was carried out in Excel 2010 (v14.0.4734.1000, 32-bit; Microsoft 
Corporation). Statistical comparisons of [3H]-PtdIns transfer activities and growth inhibition 
were calculated using the “extra sum-of-squares F-test” in Graphpad prism v 5.00.
Molecular graphics and chemical drawing
Molecular graphics and analyses were performed with the UCSF Chimera package (version 
1.8; http://www.cgl.ucsf.edu/chimera/). Chemical structures in main figures were 
constructed using ChemBioDraw (PerkinElmer, Cambridge, MA). Chemical structures, 
substructures and reactions in Supplementary Figures were drawn and displayed using 
Marvin (5.10.0 and 5.11.4, 2012) and ChemAxon (http://www.chemaxon.com). Docking 
poses and cavity surfaces were generated using MOE suite (2011.10; Chem. Comp. Group 
Inc., Montreal, Canada).
Yeast strains, media and reagents—Yeast media and transformation methods are 
described 46. Restriction endonucleases were from New England Biolabs (Ipswich, MA), 
standard reagents from Sigma (St. Louis, MO) or Fisher Scientific (Norcross, GA), and all 
phospholipids were purchased from Avanti Polar Lipids Inc. (Alabaster, AL). [35S]-
Translabel was purchased from MP Biomedicals (Irvine, CA). Yeast strain genotypes are 
listed in Supplementary Table 1 and plasmids in Supplementary Tables 2 and 3.
Growth rate analyses
Growth assays were conducted in 96 well microtiter plates. In Supplemental Figures 1 and 
3a, optical densities were measured every 15 min over the course of 20 hours using a 
GENios microplate reader (Tecan). All other growth rates were determined as follows. Cells 
were cultured to mid-logarithmic growth phase in YPD medium (2% glucose) and diluted to 
λ600nm=0.1 in media appropriately supplemented with SMI or DMSO. Cultures were 
incubated in 96 well plates in a final volume of 250μl of YPD (2% glucose) for 10–16 hours 
between 30°C and 32°C. ODs were measured every 15 min. at λ610nm (BioTek Synergy 2) 
or λ595nm (PerkinElmer VictorX3 3030 Multilabel Plate Reader). Doubling times were 
calculated and normalized to an internal DMSO control. Nonlinear regression was applied to 
the dataset to calculate the best fit equation using [Y=100/
(1+10^((LogIC50−X)*HillSlope))] in Graphpad Prism v5.0. IC50 values represent the 95% 
confidence interval from at least three independent experiments unless otherwise noted. 
Statistical comparison of SMI-mediated growth inhibition were determined using the “extra 
sum-of-squares F-test” in Graphpad prism v 5.00.
Site-directed mutagenesis
Site-directed mutations were generated using QuickChange™ (Stratagene) as recommended 
by the manufacturer. Primer sequences are available from the authors by request.
Small molecule inhibitors—The compounds shown in Supplementary Figure 1 were 
from ChemDiv (San Diego, CA). SMIs BBV34896-755, BBV34846-244, Z1082669-326, 
BBV34846-247, BBV34847-734 were synthesized by UORSY/Ukrorgsyntez Ltd. (Riga 
Latvia). Unless otherwise noted, all other compounds were purchased from ChemBridge 
Chemical Store, San Diego, CA (www.hit2lead.com). SMIs were dissolved in DMSO 
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(Fisher, D128-500) to a final stock concentration of 20mM and stored in the dark at room 
temperature. Quality control 1H NMR spectra and LC-MS data are provided in the 
Supplementary note.
Chemogenomic screening
Pools of bar-coded homozygous and heterozygous deletion strains were grown in YPD + 
25mM HEPES (pH 6.8) supplemented with 4130-1278 (35.5μM) and 4130-1276 (6.7μM) 
for 5 and 20 generations, respectively. Genomic DNA extraction, PCR amplification of 
molecular barcodes, Genflex tag16k array hybridization/scanning (Affymetrix), and analysis 
of chemogenomic data are described19. Quantile normalized fluorescence values for each 
tag were log2-transformed, and z-scores calculated: Tag z-score = [(average of controls)−
(experimental value)]/(std. dev. of controls); where the controls were 12 replicate samples of 
pools treated with DMSO. The z-score for each strain is the average of the 2 tags associated 
with that strain, and represents the sensitivity value.
NPPM chemogenomic interactions
Interactions were described according to their Gene Ontology (GO) descriptors47. Data sets 
from chemogenomic profiling were analyzed and enriched gene sets were chosen that had Z-
scores greater than 4. Gene-sets that did not pass this enrichment threshold are not shown.
Protein purification
Recombinant proteins were purified as described10. In summary, pET28b-His8-Sec14, 
pET28b-His8 -Sfh1, pET28b-His8 –Sfh3 and pET28b-His8–Sfh4 were grown in E.coli BL21 
(DE3; New England BioLabs Inc, Ipswich, MA). Sfh2 and Sfh5 expression was driven by 
pQE30-His6-Sfh2 and pQE30-His6-Sfh5 vectors in E.coli strain KK218625. Recombinant 
proteins of interest were bound to TALON metal affinity beads (Clontech, Mountain View, 
CA), and eluted with imidazole (10mM–200mM gradient) and dialyzed (Prod # 68100, 
Thermo Scientific, Rockford, IL). In the case of Sec14, dialysis was against 300mM NaCl, 
25mM Na2HPO4 (pH=7.5), 5mM β-mercapthoethanol. Purified Sfh proteins were dialyzed 
against the same buffer with the exception that 50mM Na2HPO4 was used. Proteins mass 
was quantified by SDS-PAGE with BSA standard and A280.
PtdIns-transfer assays
[3H]-PtdIns-transfer assays were performed using established methods10. In assays 
involving SMI, purified recombinant PITP was pre-incubated in the presence of acceptor 
membranes, buffer (300mM NaCl, 25mM Na2HPO4, pH 7.5) and SMI for 30 min. at 37°C 
prior to initiating the assay by addition of radiolabeled donor membranes. Fractional transfer 
of [3H]-PtdIns was normalized to mock DMSO controls. Nonlinear regression was applied 
to the dataset to calculate the best fit equation using [Y=100/
(1+10^((LogIC50−X)*HillSlope))] in Graphpad Prism v5.0. Statistical comparisons of 
inhibition was calculated using “extra sum-of-squares F-test” in Graphpad prism v 5.00.
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Metabolic labeling and immunoprecipitation
Strains were grown in minimal media lacking methionine and cysteine to mid-logarithmic 
phase (OD600nm ~ 0.5). Where indicated, cultures were treated with 20μM SMI or shifted to 
37°C for 2h and radiolabeled with 20μCi/ml [35S]-amino acids (Translabel; MP 
Biomedicals). Chase was initiated by addition of unlabeled methionine and cysteine (2 mM 
each, final concentration) and terminated with trichloroacetic acid (5% wt/vol, final 
concentration). CPY immunoprecipitation, SDS-polyacrylamide gel electrophoresis 
(PAGE), and autoradiography were performed as described48. In washout experiments, 
cultures were pulse-radiolabeled and subjected to chase. Cells were then pelleted (30sec at 
4,000rpm), washed 2X with fresh YPD medium, resuspended in YPD containing 
cyclohexamide (100μg/ml), and further incubated for the indicated times at 30°C. 
Subsequently, cells were poisoned with trichloroacetic acid (5% wt/vol, final concentration) 
and samples further processed as described above.
Phosphoinositide analyses
Samples were prepared as described 32,33. Strain CTY100 (sec14-1ts, sac1Δ) was grown 
overnight in uracil-free minimal media containing 2% glucose, 1% case amino acids and 
labeled to steady state for at least 20h with 10μCi/ml [3H]-myo-inositol (ART 0116A; 
American Radiolabeled Chemicals Inc., St. Louis, MO). Cells were either shifted to 37°C, 
or challenged with NPPM or DMSO vehicle for 3h, as appropriate. Labeling was terminated 
with trichloroacetic acid (5% final concentration) and samples incubated on ice for 30 min. 
Cells were pelleted (10,000 rpm for 1 min), washed twice in 500μl of cold ddH2O, and 
resuspended in 500μl 4.5% perchloric acid. Approximately, 300μl of 0.5mm glass beads 
were added and cells disrupted by vigorous agitation for 10 min in 1 min bursts with 1 min 
rest on ice.
In experiments where inositol-glycerophospholipids were deacylated and resolved by strong 
anion exchange HPLC, bulk lipids were extracted as previously described with 
modification49. Bulk lipids were extracted in 2x 250μl of CH3CH2OH:ddH2O: 
(C2H5)2O:C4H9OH (15:15:5:1 vol/vol), dried under N2 gas, and deacylated by resuspension 
in 300μl of CH3OH:ddH2O: C4H9OH:CH3NH2 (0.8:0.6:0.2:0.35 vol/vol) and incubation for 
30 min. at 53°C 50. 100μl of cold CH3CH2CH2OH was added to the solution, the liquid 
centrifuged to dryness under vacuum, and dessicate resuspended in 400μl ddH2O. The 
solution was extracted 2X with 750μl 1-butanol:petroleum ether:ethyl formate (20:4:1 
v/v/v), adjusted to 10mM (NH4)3PO4, (pH 3.5), and soluble glycero-phosphoinositols 
resolved and quantified by HPLC.
In experiments where phosphoinositides were quantified by thin layer chromatography, 
lysates from disrupted cells was collected and centrifuged at 13,000 rpms for 10 min., the 
pellet washed with 500μl of 100mM EDTA (pH 7.4), and resuspended in 500μl of 
CHCl3:CH3OH:HCL (2:1:0.007). A two-phase system was produced by addition of 100μl of 
0.6M HCl, the sample vortexed for 5 min., and sample centrifuged for 5 min. (13,000 rpm). 
The organic phase was collected, washed 2X with 250μl of CH3OH:0.6M HCl:CHCl3 
(1:0.94:0.06), dried under N2 gas and resuspended in 50μl CHCl3. Samples were resolved by 
thin layer chromatography on Partisil LK6DF 60Å silica gel plates (Whatman, Cat# 
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4866-821) using a CHCl3:CH3OH:ddH2O:NH4OH (1:0.83:0.15:0.1) solvent system. Lipids 
were visualized by autoradiography and quantified with ImageJ (version 1.47t, National 
Institute of Health).
[3H]-Serine labeling of yeast
[3H]-Serine radiolabeling of yeast was performed as described13. The indicated strains were 
grown overnight at 30°C in uracil- and serine-free minimal media containing glucose (3%), 
ethanolamine (2mM), and sub-cultured to a λ600nm=0.3. Cells were metabolically 
radiolabeled for 3h with 3.33μCi/ml L-[3-3H]-serine (ART 0246; American Radiolabeled 
Chemicals Inc., St. Louis, MO), and either shifted to 37°C, or challenged with 6748-481 
(20μM) or DMSO for 3h, as appropriate. Labeling was terminated upon addition of ice-cold 
trichloroacetic acid (10% final concentration), and samples were incubated on ice for 30 
min. Pellets were washed 2X with cold ddH2O and re-suspended in ddH2O:absolute ethanol 
(1:4, v/v) at 100°C for 45 min. The aqueous phase was re-extracted with CHCl3:CH3OH:
0.2M KCl (4:4:3.3 v/v/v). The organic phase was washed 2X with PBS: CH3OH (9:10, v/v), 
dried under N2 gas, and the lipid film re-suspended in CHCl3:CH3OH (2:1, v/v) with 
1mg/ml of butylated hydroxytoluene. Lipids were resolved by Silica Gel H thin layer 
chromatography (Analtech, Newark, DE) in a CHCl3:2-propanol:0.25% KCl:triethylamine 
(30:9:6:18, v/v/v/v) solvent system. Plates were sprayed with 0.2% (w/v) 8-anilino-1-
napthalenesulfonic acid, and lipids visualized under UV illumination. Individual lipid 
species were identified by internal standards (Avanti), collected, and radioactivity quantified 
by liquid scintillation counting. Sample loads were normalized by total cpm.
Homology modeling of the Sec14 closed conformer
A homology model for the closed Sec14 conformer was generated using Modeller51 based 
on the templates of the open conformer of Sec14 (PDB ID 1AUA) 52 and the closed 
conformer of Sfh1 bound to PtdIns (PDB ID 3B7N) 10. Gate residues in the Sec14 open 
conformation (I215 – Y247) were removed from that template structure prior to modeling 
whereas the corresponding gate residues in the closed conformation in Sfh1/PtdIns were 
retained. In addition, residues A84 – Q111 on the far side of the binding pocket from the gate 
were removed from the Sfh1 template prior to modeling since they were structurally 
divergent from the corresponding Sec14 residues.
Docking simulations
Several independent docking platforms were used. These included; GOLD [CCDC]53; 
Glide54; QM Polarized Ligand Docking [QM-PLD]55. Details are presented below.
GOLD docking
Computational docking used the genetic algorithm-based ligand docking program GOLD 
(version 3.0.25)53. GOLD exhaustively explores ligand conformations and provides limited 
flexibility to protein side chains with -OH groups by reorienting the H-bond donor and 
acceptor groups. GOLD scoring function is based on favorable conformations found in 
Cambridge Structural Database, and on empirical results of weak chemical interactions. The 
active site was defined by a single solvent accessible point near the center of the protein 
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active site, a radius of ~10 Å, and the GOLD cavity detection algorithm. GOLD docking 
was unconstrained to obtain unbiased results and to explore all possible ligand binding 
modes. Ligand was docked in independent runs, 50 solutions were produced for each run, 
(except for one where 20 were generated), as opposed to the default of 10, and early 
termination of ligand docking was switched off. All other parameters were defaults. All 
ligands were docked using the same parameters.
Hydropathic scoring
HINT (Hydropathic INTeractions) scoring function was used to analyze docking solutions 
(version 3.11S b)56,57. HINT evaluates each atom-atom interaction in a biomolecular 
complex using a parameter set derived from solvation partition coefficients for 1-octanol/
water. The thermodynamic parameter Log Po/w is directly correlated with free energy. HINT 
describes specific interactions between two molecules as:
where a is the hydrophobic atom constant derived from Logo/w, S is the solvent accessible 
surface area, T is a function that differentiates polar-polar interactions (acid–acid, acid–base 
or base–base), and R, r are functions of the distance between atoms i and j as previously 
described 57. The binding score, bij, describes the specific atom–atom interaction between 
atoms i and j, whereas B describes the total interaction. For selection of the optimum docked 
conformation and to further differentiate the relative binding efficacy of the NPPM ligands, 
interaction scores were calculated for each pose found by docking. The protein and ligands 
were partitioned as distinct molecules. ‘Essential’ hydrogen atoms, that is, only those 
attached to polar atoms (N, O, S, P), were explicitly considered in the model and assigned 
HINT constants. The inferred solvent model, where each residue is partitioned based on its 
hydrogen count, was applied. The solvent accessible surface area for the amide nitrogens 
was corrected with the ‘+20’ option.
Glide docking
Protein and ligands were prepared using Protein Preparation Wizard and LigPrep module of 
Maestro 9.2 Interface of Schrodinger Suite (Schrodinger Suite 2012; Glide version 5.8). 
Receptor Grids were generated without using any constraints and standard settings were 
used. Docking was performed using Standard Glide and QM-PLD modules with SP and XP 
scoring function respectively. No similarity, torsional and inter-molecular interaction 
(hydrogen bonding or hydrophobic) constraints were used. Ligand was docked flexibly with 
nitrogen inversions and ring sampling turned on with post-docking minimization.
PLIF
Protein-Ligand Interaction Fingerprint (PLIF) was calculated within MOE suite (2011.10; 
Chem. Comp. Group Inc., Montreal, Canada). PLIF was calculated between a closed Sec14 
conformer and 6 representative binding modes produced by the docking runs. The protein 
Ligand Interaction Fingerprint (PLIF) is a method to encapsulate the interaction between 
ligands and proteins using a fingerprint scheme. To generate PLIF within MOE, maximum 
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250 bits were used with Min Score 1 turned off and keeping the Min Score 2 to its default 
value.
Simulation of charge distribution on activated aryl halides
Wave function calculations were carried out using the PC Spartan package (Wavefunction 
Inc. Irvine, CA; version 10 1.1.0). Starting geometries were obtained using Spartan’s 
interactive building mode, and pre-optimized using the MMFF force field. Wave functions 
were approximated using the Hartree-Fock method at the 3–21G(*) gaussian basis set. 
Electrostatic potentials were generated onto surfaces of molecular electron densities (0.002 
electrons per A3).
Fluorescence imaging
N-[3-Triethylammoniumpropyl]-4-[p-diethylaminophenylhexatrienyl] pyridinium dibromide 
(FM4-64; Invitrogen, Carlsbad, CA) staining was performed as described below. Cells were 
grown to mid-logarithmic phase (OD600 nm=0.5) in YPD medium at 30°C, then either 
shifted to 37°C for 2h or treated with 20μM SMI at 25°C for 2 h. Subsequently, cells were 
pulsed with 10μM FM4-64 (Invitrogen) for 15 min. washed 2X in YPD media matched to 
the appropriate drug or temperature condition. Labeling was terminated at indicated times by 
washing cells in NaN3/NaF (1mM final concentration of each) and placing samples on ice 
prior to imaging.
Cultures for GFP-Snc1 imaging were grown in synthetic defined medium lacking uracil at 
30°C. Cells processed for imaging of phosphoinositide biosensors were collected from 
liquid cultures grown in uracil-free YNB supplemented with 3% glucose and 1% casamino 
acids at 25°C by centrifugation at 4,000 rpm for 1 min, and resuspended into fresh uracil-
deficient medium prior to analysis. Cells were immobilized onto a thin layer of growth 
medium with 20% gelatin (G-2500, Sigma-Aldrich), sealed under a coverslip with Valap, 
and examined at 25°C. The imaging system employed a CFI plan apochromat lambda 100x 
oil immersion objective lens NA 1.45 mounted on a Nikon Ti-U microscope base (Nikon, 
Melville, NY) interfaced to a Photometrics CoolSNAP HQ2 high sensitivity monochrome 
CCD camera (Roper Scientific, Ottobrunn, Germany) or an Andor Neo sCMOS CCD 
camera (Andor Technology, Belfast, UK). A Lumen 200 Illumination System (Prior 
Scientific Inc., Rockland, MA.) was used in conjunction with a B-2E/C (465–495nm/515–
555nm;EX/EM) or G-2E/C (528–553nm/590–650nm;EX/EM) filter set (Nikon, Melville, 
NY). Images were captured using the Nikon NIS Elements software package (Nikon, 
Melville, NY, version 4.10) and exported as .TIF files. Image analyses were performed 
using ImageJ (version 1.47t, National Institute of Health) and figures were constructed using 
Adobe Illustrator and Adobe Photoshop CS6 (version 15.0.0).
Transmission electron microscopy
Yeast were grown to an OD600 nm=0.5 and cultures were either shifted to 37°C for 2 hours 
or challenged with 20μM SMI for 2 hours at 30°C. Cells were fixed in 3% glutaraldehyde, 
converted to spheroplasts, stained with 2% OsO4 and 2% uranyl acetate, dehydrated in a 
50%, 70%, 90% ethanol series, and washed in 100% ethanol and 100% acetone, 
respectively. Cell pellets were embedded into Spurr’s resin at 60°C for 48h and sectioned58. 
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Thin sections produced from strains in the SEC14p-136 (CTY374) background were imaged 
at 80 kV on a Tecnai 12 electron microscope (FEI, Hillsboro, OR), and images captured 
using Gatan micrograph with version 3.9.3 software (Gatan, Pleasanton, CA). All other 
samples were visualized on a Jeol 1200 EX TEM operated at an accelerating voltage of 100 
kV. Images were captured at calibrated magnifications using an optically coupled 3k slow 
scan CCD camera (model 15C, SIA, Duluth, GA) and Maxim DL imaging software.
Invertase secretion assays
Cells were grown in YPD (2% glucose) at 30°C, cultures were split, and cells incubated at 
30°C ± NPPM (20μM) or DMSO or 37°C for 1h in YPD (2% glucose). Cells were then 
pelleted (2000g), washed twice with pre-warmed YPD (0.1% glucose), resuspended in the 
low glucose YPD medium, and incubated as before for 1.5h. To halt trafficking, samples 
were adjusted to 10mM NaN3, and incubated on ice. The samples were washed 3X with 
500μl ice-cold 10mM NaN3 and re-suspended in 500μl of the same. The samples were split 
into 10mM NaN3 buffers ± 0.2 % Triton X-100 (final) with the Triton-solubilized fractions 
also being subjected to one cycle of freeze-thaw to generate the permeabilized cell fraction. 
The partner non-permeabilized and permeabilized samples were used to determine 
extracellular and total invertase activities, respectively59. Invertase units were expressed as 
nmoles of glucose produced per min. at 30°C.
Sequence alignment
Protein sequences were acquired from the Universal Protein Resource, aggregated using 
UGENE (version 1.10.1; http://ugene.unipro.ru/), and aligned with the T-Coffee module 
using the default settings. Homologous sequences were superimposed onto structural models 
(PDB IDs 1AUA, 1OLM, 3B7Z, 4FMM) to highlight the PtdIns/PtdCho lipid binding 
barcode.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. NPPMs specifically inactivate Sec14
(a) Chemical structures of 4130-1278, 4130-1276, 67170-49, 6748-481, and 5564-701. (b) 
Growth inhibition of wild-type (WT; CTY182, gray) and SEC14P-136 (CTY374; black) 
strains by 6748-481 (●,■; IC50s=2.87±0.6 and 0.44±0.16μM, respectively) or 5564-701 
(▲,◆; IC50s>200μM). Relative growth compares growth rate with compound relative to 
“no-drug” control (DMSO). Data are plotted as function of NPPM concentration (x-axis). 
Doubling times were measured at λ610nm. Values show mean ± s.e.m of normalized 
doubling times for each drug concentration from 3 independent experiments. IC50s represent 
95% confidence interval from 3 independent experiments. (c) Yeast expressing 
physiological [YCp(SEC14)], or elevated [YEp(SEC14)], Sec14 levels were spotted in 10-
fold dilution series onto YPD agar with DMSO or 6748-481 (20μM) and incubated at 30°C 
(48h). Bar, 1cm. (d) [3H]-PtdIns-transfer was monitored in vitro using purified Sec14 with 
5564-701 (IC50>100μM), 4130-1276 (IC50=283 ± 30nM), 6748-481 (IC50=211 ± 19nM) or 
67170-49 (IC50=175 ± 26nM). Relative [3H]-PtdIns transfer relates activity in presence of 
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NPPM relative to vehicle control (DMSO) in assays where Sec14 concentration was 
clamped (287nM). Values indicate mean ± s.e.m of triplicate determinations from 3 
independent experiments. IC50 values fall into 95% confidence intervals. [3H]-PtdIns input 
ranged from 12790–16800 cpm, with background ranging from 478–751 cpm. (e) Purified 
Sfh proteins (10μg) were assayed for [3H]-PtdIns transfer in the presence and absence of 
indicated NPPM (40μM). Values are the mean ± s.d of triplicate determinations from 3 
independent experiments. P*=1.8202E−11 and P**=4.31133E−12 relative to DMSO control 
(two-tailed t-test with heteroscedastic variance, Microsoft Excel 2010). [3H]-PtdIns input 
ranged from 14441–15101 cpm, with background ranging from 640–657 cpm.
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Figure 2. NPPM SAR relationships
(a) A summary of the contributions of each highlighted functional group of NPPM 6748-481 
to potency as Sec14 inhibitor is depicted. Data represent a compilation, and superimposition 
onto the 6748-481 scaffold, of IC50 measurements for Sec14-catalyzed [3H]-PtdIns transfer 
activity for each SMI listed in Supplementary Figure 4. (b–e) Chemical-induced inhibition 
of Sec14-catalyzed [3H]-PtdIns transfer activity was monitored in the presence of the 
indicated SMI. Chemical identities for functional groups X, Y and Z are identified for each 
SMI tested, and are highlighted in red. Relative [3H]-PtdIns transfer compares activity in 
presence of compound relative to the “no-drug” control (DMSO) in assays where Sec14 
concentration was clamped at 287nM. IC50 values: 5355-152 (>100,000 nM),5658-722 
(>100,000 nM), 5348-723 (11,060 ± 1,130 nM), 6748-481 (211 ± 19 nM), BBV34896-755 
(36,800 ± 5,000 nM), BBV34846-247 (173 ± 35 nM), BBV34846-244 (100 ± 6 nM), 
Z1082669-326 (174 ± 17 nM), 5356-628 (>100,000 nM), 5567-782 (56,500 ± 7,680 nM), 
5356-350 (22,000 ± 3,100 nM), 5357-399 (2,550 ± 230 nM), 5353-036 (768 ± 71 nM), 
7329-906 (589 ± 51 nM), 5656-333 (>100,000 nM), 6031-920 (>100,000 nM), 5353-383 
(>100,000 nM), 5653-520 (>100,000 nM). [3H]-PtdIns input ranged from 7,542-13,002 cpm 
per assay, with background ranging from 282-1,317 cpm and transfer efficiency (% of total 
input) ranged from 11% to 32%. Values indicate the mean ± s.e.m of triplicate 
determinations from three independent experiments. IC50 values represent the 95% 
confidence interval or for single concentration points a predicted IC50. Statistical 
comparisons of values used the “unpaired two-tailed t-test” where P***<0.0001, 
P**=0.0024 and P*=0.0089.
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Figure 3. Sec14 is the essential cellular target of bioactive NPPMs
[3H]-PtdIns transfer was measured using purified recombinant Sec14 proteins (287nM) in 
the presence of 6748-481. (a) Relative [3H]-PtdIns transfer compares activities in presence 
of 6748-481 relative to the “no-drug” control (DMSO). Input ranged from 9,227–16985 cpm 
per assay (background; 160–724 cpm). Transfer efficiencies: Sec14 (24–32%), Sec14Y111A 
(5–13%), Sec14Y111F (38–41%), Sec14Y122A (13–15%), Sec14Y122F (18–27%), Sec14Y151A 
(31–40%), Sec14Y151F (31–40%), Sec14S173C (22–24%), Sec14T175C (5–16%), Sec14S201C 
(6–11%), Sec14M177C (8–10%), and Sec14F228A (18–27%). IC50 values represent 95% 
confidence interval of triplicate determinations from three independent experiments. 
Statistical comparisons of WT to mutant IC50 values used “extra sum-of-squares F-test” 
(P***<0.0001). (b) Expression of NPPM-resistant Sec14 derivatives renders cells 
insensitive to NPPM-mediated growth arrest. Yeast expressing physiological levels of 
Sec14, YCp(SEC14), or the indicated Sec14 variant, as the sole source of Sec14 in the cell, 
were diluted in 10-fold series onto YPD agar containing DMSO, 20μM or 40μM 6748-481. 
Plates were incubated at 30°C (48h). (c) ‘Bypass Sec14’ mutants are NPPM-resistant. WT 
(CTY182), SEC14P-136 (CTY374), and sec14Δ cki1Δ (CTY303) and sec14-1ts kes1Δ 
(CTY159) ‘bypass Sec14’ mutants were grown as in (b). Bar, 1cm.
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Figure 4. Sec14-active NPPMs exhibit compartment-specific inhibition of PtdIns-(4)-phosphate 
signaling
(a) WT yeast (CTY182) or the indicated temperature sensitive mutants containing 
GFP-2xPHOsh2 were treated with indicated SMIs (20μM) for 3h at 25°C, or 37C. 
GFP-2xPHOsh2 profiles were imaged, and profiles scored. (b) GFP-2xPHOsh2 distributions 
were classified as PM, punctate, or both. ND – not determined. At least 300 cells were 
scored for each condition in (a). (c) Experimental conditions were as in (a) except GFP-
GOLPH3 distribution was monitored. The mss4-5ts mutant was incubated for 30 min. at 
non-permissive temperature. (d) GFP-GOLFP3 distribution was scored (>300 cells for each 
condition), and GFP-GOLPH3 distributions were classified as PM, punctate, or both. Bar, 
5μm.
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Figure 5. NPPMs discriminate between Sec14- and Sfh4-mediated PtdIns-4-P signaling
(a) Sec14 and Sfh4 control distinct PtdIns-4-P signaling pathways in TGN/endosomal 
compartments. Sec14 couples PtdIns 4-OH kinase action with vesicle biogenesis, whereas 
Sfh4 pathway couples PtdIns 4-OH kinase action with PtdSer decarboxylation to PtdEtn. 
Decarboxylation is catalyzed by Psd2 and is posited to involve membrane contact sites that 
bridge the endoplasmic reticulum (ER) with TGN/endosomes. (b) psd1Δ (PYY23), sfh4Δ 
(PYY40), or sfh4Δ psd1Δ (PYY30) yeast expressing the NPPM-resistant Sec14S173C 
[YCp(SEC14S173C)] were spotted in 10-fold dilution series on uracil-free agar ± 
ethanolamine (1mM), with or without 6748-481 (20μM). Plates were incubated at 30°C 
(96h). (c) WT (CTY182), sec14-1ts (CTY1-1A), psd1Δ (PYY23), sfh4Δ (PYY40), or sfh4Δ 
psd1Δ (PYY30) cells expressing Sec14 or Sec14S173C were cultured in uracil-free media 
containing ethanolamine (2mM) at 30°C. Mid-logarithmic growth phase cultures (λ600=0.3) 
were incubated with [3H]-serine (3.3μCi/ml) for six hours. At hour three, cells were 
presented with 6748-481 (20μM), DMSO, or shifted to non-permissive temperature (37°C). 
Lipids were extracted and resolved by thin layer chromatography. PtdSer and PtdEtn species 
were harvested, quantified by liquid scintillation counting, and data expressed as precursor/
product ratios. Values represent mean ± s.e.m from at least 3 independent experiments. 
Defects in Sfh4-dependent conversion of PtdSer to PtdEtn present high PtdSer/PtdEtn ratios 
– e.g. psd1Δ sfh4Δ control strains. Statistical comparisons of values used the ‘unpaired two-
tailed t-test” relative to DMSO control, where # (P = 0.0495), ## (P = 0.002), ** (P = 
0.0051), *** (P = 0.0004). Bar, 1 cm.
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Figure 6. Model for NPPM-mediated inhibition of Sec14
(a) Simulations of the electrostatic potentials of the indicated NPPM activated aryl halides 
predict formation of progressively larger electropositive σ-holes in the -Cl, -Br and -I 
activated aryl halides, respectively. The -CH3 and -F derivatives are forecast to be incapable 
of forming significant σ-holes. (b) NPPM binding mode 2 is most consistent with the 
various data and is depicted within the Sec14 hydrophobic pocket. H-bonds (orange), carbon 
(blue), oxygen (magenta), nitrogen (dark blue), chlorine (teal) and fluorine (orange). (c) A 
focused view of NPPM binding mode 2 highlighting Sec14 residues which form the PtdCho 
headgroup coordinating substructure, and whose alteration renders Sec14 resistant to NPPM 
inhibition. Hydrogen bonds (orange), carbon (blue), oxygen (red), nitrogen (dark blue), 
chlorine and fluorine (green).
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